Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Given Consensus Recommendation of “Buy” by Brokerages

Shares of Reckitt Benckiser Group plc (OTCMKTS:RBGLY) have been assigned a consensus rating of “Buy” from the seven analysts that are currently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, one has issued a buy recommendation and four have given a strong buy recommendation to the company.

Several brokerages recently weighed in on RBGLY. Sanford C. Bernstein cut shares of Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 4th. HSBC upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. Barclays upgraded Reckitt Benckiser Group to a “strong-buy” rating in a research report on Friday, October 4th. Hsbc Global Res raised Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, December 11th. Finally, Citigroup raised Reckitt Benckiser Group to a “strong-buy” rating in a research report on Tuesday, October 1st.

Reckitt Benckiser Group Trading Up 1.0 %

OTCMKTS:RBGLY opened at $12.69 on Friday. Reckitt Benckiser Group has a 1 year low of $10.24 and a 1 year high of $15.03. The stock’s 50 day simple moving average is $12.18 and its two-hundred day simple moving average is $11.92. The company has a quick ratio of 0.47, a current ratio of 0.69 and a debt-to-equity ratio of 0.97.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.